Skip to main content

Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter

NIEHS - National Institute of Environmental Health Sciences

open
OpenLast verified: 2026-06-20

About This Grant

Project Summary Up to 40% of the U.S. population is exposed to unhealthy air pollution, with particulate matter (PM) being a major contributor. PM exposure induces oxidative stress and inflammation and leads to severe lung diseases, which is mediated by the Aryl-hydrocarbon receptor (AhR) pathway and epithelial cytokines. Despite growing evidence, the underlying molecular mechanisms are not fully understood, limiting the development of targeted interventions. Emerging research suggests that PM exposure influences N6-methyladenosine (m6A) RNA modification, which regulates RNA stability and translation, through altering the expression of proteins adding, removing and binding to this modification ("Readers", "Writers", and "Erasers", abbreviated as "RWEs"). Intriguingly, RNA m6A "read- ers" can recruit epigenomic regulators such as DNA demethylase TET1 to alter DNA methylation and chromatin accessibility, highlighting crosstalk between RNA m6A and TET1-mediated epigenomic mechanisms. Whether RNA m6A interacts with TET1 and TET1-mediated epigenomic mechanisms in airway epithelial cells, how they interact and contribute to PM-induced lung inflammation remain as significant research gaps. In response to NIEHS RFA-ES-25-001 (EPCOT), this proposal aims to investigate the interactions between TET1-mediated epigenomic mechanisms and RNA m6A in PM-induced lung inflammation. Our preliminary data established a novel role of TET1 in protecting against PM-induced lung inflammation and remodeling, through promoting the expression of detoxifying enzymes downstream AhR signaling and restricting proinflammatory cytokines. Our data also suggest a novel, noncanonical role of TET1 in regulating chromatin accessibility and CTCF looping to regulate gene expression, in addition to DNA methylation and histone modification, in human bronchial epi- thelial cells. Importantly, we found that TET1 regulates the expression of RNA m6A RWEs in HBECs and mouse lungs, through both canonical and non-canonical roles, resulting in changes in global RNA m6A. Collectively, we hypothesize that TET1 mediates interactions between multiple epigenomic mechanisms and RNA m6A to re- strict PM-induced lung inflammation. To test this hypothesis, we will examine how TET1 regulates m6A RWEs in airway epithelial cells by analyzing 5mC/5hmC, histone modifications, chromatin accessibility, and CTCF-medi- ated looping in response to PM exposure in Aim 1. In Aim 2, we will identify genome-wide RNA m6A changes following PM exposure and TET1 loss and determine the impact of these changes on mRNA stability and protein translation of target genes, especially those contributing to lung inflammation. In Aim 3, we will identify genomic locations with both RNA m6A and TET1-regulated epigenomic features, investigate interactions between TET1 and m6A readers at these locations, and evaluate the impact of PM exposures on these interactions. Leveraging a highly collaborative research team with complementary expertise, unique PM samples and resources, and state-of-the-art technologies, the proposed research is expected to provide novel mechanistic insights into PM- induced pulmonary toxicity and disease, potentially leading to targeted interventional strategies.

Grant Summary

Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter is a NIEHS - National Institute of Environmental Health Sciences grant providing up to $750K for university, nonprofit, healthcare org. Applications are due 2031-03-31 (open). Check eligibility and apply with FindGrants.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $750K

Deadline

2031-03-31

Complexity
High
  1. 1Confirm your organization is eligible for Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter from NIEHS - National Institute of Environmental Health Sciences, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIEHS - National Institute of Environmental Health Sciences before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIEHS - National Institute of Environmental Health Sciences's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter: Frequently Asked Questions

Who is eligible for the Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter?

Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter is offered by NIEHS - National Institute of Environmental Health Sciences and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter provide?

Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter provides up to $750K per award from NIEHS - National Institute of Environmental Health Sciences. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter deadline?

Applications for Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter are due 2031-03-31 (open). Because deadlines can change, verify the date with the funder, NIEHS - National Institute of Environmental Health Sciences, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter?

To apply for Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIEHS - National Institute of Environmental Health Sciences.

Browse More Grants